Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prajnan Das

Showing results (271-280 of 324) with videos related to

Pageof 33
Sort By:
Practical Radiation Oncology|July 30, 2022
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert PanelJohn Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, et al.
Oncotarget|November 9, 2017
Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillanceElena Elimova, Rebecca S Slack, Hsiang-Chun Chen, et al.
Advances in Radiation Oncology|April 29, 2021
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic CancerShalini Moningi, Joseph Abi Jaoude, Ramez Kouzy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2025
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal CancerVan K Morris, Weihong Xiao, Kangyu Lin, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
The Annals of Thoracic Surgery|May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III AdenocarcinomaKyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Oncology|July 7, 2017
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United StatesHumaid O Al-Shamsi, Reham Abdel-Wahab, Manal M Hassan, et al.
Pageof 33

Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
Practical Radiation Oncology|July 30, 2022
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert PanelJohn Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, et al.
Oncotarget|November 9, 2017
Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillanceElena Elimova, Rebecca S Slack, Hsiang-Chun Chen, et al.
Advances in Radiation Oncology|April 29, 2021
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic CancerShalini Moningi, Joseph Abi Jaoude, Ramez Kouzy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2025
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal CancerVan K Morris, Weihong Xiao, Kangyu Lin, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
The Annals of Thoracic Surgery|May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III AdenocarcinomaKyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Oncology|July 7, 2017
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United StatesHumaid O Al-Shamsi, Reham Abdel-Wahab, Manal M Hassan, et al.
Pageof 33